164 related articles for article (PubMed ID: 14870835)
1. [Current methods in the treatment of iatrogenic neutropenia].
Meriggi F; Zaniboni A
Tumori; 2003; 89(6):12-20. PubMed ID: 14870835
[No Abstract] [Full Text] [Related]
2. Myeloid growth factors.
Crawford J; Armitage J; Balducci L; Bennett C; Blayney DW; Cataland SR; Dale DC; Demetri GD; Erba HP; Foran J; Freifeld AG; Goemann M; Heaney ML; Htoy S; Hudock S; Kloth DD; Kuter DJ; Lyman GH; Michaud LB; Miyata SC; Tallman MS; Vadhan-Raj S; Westervelt P; Wong MK;
J Natl Compr Canc Netw; 2009 Jan; 7(1):64-83. PubMed ID: 19176207
[No Abstract] [Full Text] [Related]
3. Towards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors.
Morstyn G; Sheridan W; Lieschke G; Cebon J; Layton J; Fox R
Prog Clin Biol Res; 1990; 354B():29-36. PubMed ID: 1700441
[No Abstract] [Full Text] [Related]
4. Hematopoietic growth factors for chemotherapy-induced neutropenia.
Yalçin S
Cancer Invest; 1999; 17(7):555-6. PubMed ID: 10518202
[No Abstract] [Full Text] [Related]
5. [Report on the current indications for colony stimulating factors (G-CSF and GM-CSF)].
Med Clin (Barc); 1994 May; 102(19):747-50. PubMed ID: 7518884
[No Abstract] [Full Text] [Related]
6. The use of growth factors with antibiotics in the setting of neutropenic fever.
Hussein AM; Elkordy M; Peters WP
Am J Med; 1996 Jan; 100(1):15-6. PubMed ID: 8579081
[No Abstract] [Full Text] [Related]
7. Growth factors and empiric therapy with antibiotics: should they be used concurrently?
Schimpff SC
Ann Intern Med; 1994 Oct; 121(7):538-40. PubMed ID: 7520677
[No Abstract] [Full Text] [Related]
8. Interactive discussion on chemotherapy-related adverse events.
Adams VR; Lyman GH
Pharmacotherapy; 2000 Jul; 20(7 Pt 2):121S-125S. PubMed ID: 10905688
[No Abstract] [Full Text] [Related]
9. Granulocyte-macrophage-colony-stimulating factor in established febrile neutropenia.
Mitchell PL; Pinkerton CR
J Clin Oncol; 1999 Sep; 17(9):3002. PubMed ID: 10561379
[No Abstract] [Full Text] [Related]
10. Growth factor frenzy.
Quesenberry PJ
Exp Hematol; 1993 Jul; 21(7):835-6. PubMed ID: 7686499
[No Abstract] [Full Text] [Related]
11. Comparison of sargramostim and filgrastim in the treatment of chemotherapy-induced neutropenia.
Stull DM; Bilmes R; Kim H; Fichtl R
Am J Health Syst Pharm; 2005 Jan; 62(1):83-7. PubMed ID: 15658078
[No Abstract] [Full Text] [Related]
12. Colony-stimulating factors in the prevention of solid tumors induced by chemotherapy in patients with febrile neutropenia.
Freyer G; Ligneau B; Trillet-Lenoir V
Int J Antimicrob Agents; 1998 Apr; 10(1):3-9. PubMed ID: 9624538
[TBL] [Abstract][Full Text] [Related]
13. [Place of CSF in pediatric oncology].
Hartmann O; Valteau-Couanet D
Pathol Biol (Paris); 1993 Jan; 41(1):52. PubMed ID: 7686289
[No Abstract] [Full Text] [Related]
14. [Prevention and treatment of febrile neutropenia].
Montemurro F; Gallicchio M; Aglietta M
Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
[TBL] [Abstract][Full Text] [Related]
15. Colony-stimulating factors: clinical evidence for treatment and prophylaxis of chemotherapy-induced febrile neutropenia.
Gómez Raposo C; Pinto Marín A; González Barón M
Clin Transl Oncol; 2006 Oct; 8(10):729-34. PubMed ID: 17074671
[TBL] [Abstract][Full Text] [Related]
16. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
17. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
[TBL] [Abstract][Full Text] [Related]
18. [Recommendation for using granulocyte and granulocyte-macrophage growth factor during anti-cancer therapy in children].
Balwierz W; Moryl-Bujakowska A; Balwierz A; Pawińska K
Przegl Lek; 2006; 63(1):1-6. PubMed ID: 16892890
[TBL] [Abstract][Full Text] [Related]
19. [Acute myeloic leukemia: evaluation of colony-stimulating factors].
Hiddemann W
Dtsch Med Wochenschr; 2012 Nov; 137(45):2306. PubMed ID: 23111791
[No Abstract] [Full Text] [Related]
20. The therapeutic use of hematopoietic growth factors.
Costa JJ
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):1-6. PubMed ID: 9449493
[No Abstract] [Full Text] [Related]
[Next] [New Search]
